Neurocrine Biosciences
NBIX
#1521
Rank
A$18.04 B
Marketcap
$180.96
Share price
-0.39%
Change (1 day)
-14.15%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): A$0.77 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are A$2.35 Billion. , an increase over its 2023 earnings that were of A$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 A$0.81 B64.57%
2023 A$0.49 B41.13%
2022 A$0.35 B73.74%
2021 A$0.20 B-8.82%
2020 A$0.22 B77.78%
2019 A$0.12 B49.83%
2018 A$83.13 M-142.57%
2017 -A$0.2 Billion-14.73%
2016 -A$0.23 Billion53.15%
2015 -A$0.15 Billion46.25%
2014 -A$0.11 Billion29.66%
2013 -A$78.86 Million-3530.8%
2012 A$2.29 M-95.73%
2011 A$53.84 M
2009 -A$75.7 Million-45.38%
2008 -A$0.14 Billion-58.87%
2007 -A$0.34 Billion87.3%
2006 -A$0.18 Billion351.97%
2005 -A$39.8 Million-52.09%
2004 -A$83.08 Million-10.98%
2003 -A$93.32 Million
2001 -A$69.66 Million
1999 -A$31.42 Million108.32%
1998 -A$15.08 Million
1996 A$4.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$30.51 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.47 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-A$42.76 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.12 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.89 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.64 B 2,065.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$35.26 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$66.3 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA